Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001568675 | SCV001792589 | likely benign | not provided | 2020-12-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001568675 | SCV002355656 | likely benign | not provided | 2025-01-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002568448 | SCV003742672 | uncertain significance | Inborn genetic diseases | 2024-08-28 | criteria provided, single submitter | clinical testing | The c.3686G>A (p.R1229H) alteration is located in exon 8 (coding exon 7) of the DCHS1 gene. This alteration results from a G to A substitution at nucleotide position 3686, causing the arginine (R) at amino acid position 1229 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003985508 | SCV004118150 | uncertain significance | DCHS1-related disorder | 2023-02-08 | criteria provided, single submitter | clinical testing | The DCHS1 c.3686G>A variant is predicted to result in the amino acid substitution p.Arg1229His. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.051% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/11-6652628-C-T). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |